Literature DB >> 16135250

The case for not restricting saturated fat on a low carbohydrate diet.

Jeff S Volek1, Cassandra E Forsythe.   

Abstract

Entities:  

Year:  2005        PMID: 16135250      PMCID: PMC1208952          DOI: 10.1186/1743-7075-2-21

Source DB:  PubMed          Journal:  Nutr Metab (Lond)        ISSN: 1743-7075            Impact factor:   4.169


× No keyword cloud information.
We would like to compliment Drs. Arora and McFarlane on their timely review of low carbohydrate diets in diabetes management [1]. Undeniably, the prescription of low-fat, high-carbohydrate diets to treat diabetes has to be questioned and the power of carbohydrate restriction seriously considered. The article dispels common myths and provides a convincing argument for successful use of carbohydrate restriction in treating diabetes. One point stressed by Arora and McFarlane was that mono and polyunsaturated fat should be emphasized over saturated fat as a way to achieve caloric balance on a carbohydrate-restricted diet. We contend that the recommendation to intentionally restrict saturated fat is unwarranted and only serves to contribute to the misleading rhetoric surrounding the health effects of saturated fat. We believe restriction of saturated fat is not warranted on a low-carbohydrate diet because of our work showing favorable responses in clinical risk factors for diabetes and cardiovascular disease in low-carbohydrate diets that were rich in saturated fat [2]. In addition, German & Dillard [3] have reviewed several experimental studies of the effects of saturated fats and the results are found to be variable and there is a general failure to meet the kind of unambiguous predictions that would justify the recommendation to reduce saturated fat in the population [3]. Other critical reviews of the evidence [4] have questioned whether public health recommendations for reducing saturated fat intake [5] are appropriate. The critical issues are: 1. The atherogenic potential of saturated fats varies greatly depending on chain length and whether it is present alone or added in foods. Stearic acid (C18) is a major saturated fat found in beef, chicken, and pork and has repeatedly been shown not to raise LDL cholesterol levels [6]. Even palmitic acid (C16), the most abundant saturated fatty acid in the diet, does not raise LDL cholesterol in the presence of adequate linoleic acid [7]. 2. The effect of saturated fat cannot be assumed to be independent of specific dietary conditions. In particular, hypocaloric or low total fat diets may show different results than deduced from epidemiology. A recent report [8] showed that for a woman on a relatively low fat diet, a greater saturated fat intake was associated with a reduced progression of coronary atherosclerosis. An editorial described this as "an American paradox [9]. 3. Evaluation of the overall health effects of saturated fat requires consideration of markers in addition to LDL-cholesterol. Isocaloric replacement of carbohydrate with any type of fat results in decreased triglycerides and increased HDL-cholesterol, the effect on HDL-cholesterol being greater for saturated fat compared to unsaturated fat [10]. Reductions in saturated fat also adversely affect HDL subpopulations by decreasing larger HDL2-cholesterol concentrations [11], whereas increases in saturated fat increase this antiatherogenic fraction [12,13]. Furthermore, very low-carbohydrate diets rich in saturated fat increase LDL size and conversion from a high-risk pattern B to a lower risk pattern A phenotype [2]. 4. Finally, there is the concern that recommendations to limit saturated fat would lead to their replacement with carbohydrate, which can have undesirable effects (increased triglycerides with decreased HDL cholesterol) [10]. For these reasons, we believe that the recommendation to restrict saturated fat in favor of unsaturated fat on a low-carbohydrate diet is unnecessary and may even diminish some of the beneficial physiological effects associated with carbohydrate restriction. At the very least, the food restriction required to reduce saturated fat will compromise the palatability of the diet and ultimately the acceptance of the approach to diabetes management recommended by Arora and McFarlane [1].
  13 in total

1.  Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

Authors:  Paula Trumbo; Sandra Schlicker; Allison A Yates; Mary Poos
Journal:  J Am Diet Assoc       Date:  2002-11

2.  HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects.

Authors:  L Berglund; E H Oliver; N Fontanez; S Holleran; K Matthews; P S Roheim; H N Ginsberg; R Ramakrishnan; M Lefevre
Journal:  Am J Clin Nutr       Date:  1999-12       Impact factor: 7.045

3.  A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity.

Authors:  Prakash Seshadri; Nayyar Iqbal; Linda Stern; Monica Williams; Kathryn L Chicano; Denise A Daily; Joyce McGrory; Edward J Gracely; Daniel J Rader; Frederick F Samaha
Journal:  Am J Med       Date:  2004-09-15       Impact factor: 4.965

Review 4.  Dietary oils, serum lipoproteins, and coronary heart disease.

Authors:  M B Katan; P L Zock; R P Mensink
Journal:  Am J Clin Nutr       Date:  1995-06       Impact factor: 7.045

Review 5.  Saturated fats: what dietary intake?

Authors:  J Bruce German; Cora J Dillard
Journal:  Am J Clin Nutr       Date:  2004-09       Impact factor: 7.045

Review 6.  Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids.

Authors:  S M Grundy
Journal:  Am J Clin Nutr       Date:  1994-12       Impact factor: 7.045

7.  Cholesterolaemic effect of palmitic acid in relation to other dietary fatty acids.

Authors:  Margaret A French; Kalyana Sundram; M Thomas Clandinin
Journal:  Asia Pac J Clin Nutr       Date:  2002       Impact factor: 1.662

8.  Effect of a high saturated fat and no-starch diet on serum lipid subfractions in patients with documented atherosclerotic cardiovascular disease.

Authors:  James H Hays; Angela DiSabatino; Robert T Gorman; Simi Vincent; Michael E Stillabower
Journal:  Mayo Clin Proc       Date:  2003-11       Impact factor: 7.616

Review 9.  The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease.

Authors:  U Ravnskov
Journal:  J Clin Epidemiol       Date:  1998-06       Impact factor: 6.437

10.  The case for low carbohydrate diets in diabetes management.

Authors:  Surender K Arora; Samy I McFarlane
Journal:  Nutr Metab (Lond)       Date:  2005-07-14       Impact factor: 4.169

View more
  5 in total

1.  Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction.

Authors:  Jeff S Volek; Richard D Feinman
Journal:  Nutr Metab (Lond)       Date:  2005-11-16       Impact factor: 4.169

2.  Low carbohydrate diets in family practice: what can we learn from an internet-based support group.

Authors:  Richard D Feinman; Mary C Vernon; Eric C Westman
Journal:  Nutr J       Date:  2006-10-02       Impact factor: 3.271

3.  Three-Year Chronic Consumption of Low-Carbohydrate Diet Impairs Exercise Performance and Has a Small Unfavorable Effect on Lipid Profile in Middle-Aged Men.

Authors:  Karol Pilis; Anna Pilis; Krzysztof Stec; Wiesław Pilis; Józef Langfort; Sławomir Letkiewicz; Cezary Michalski; Miłosz Czuba; Michał Zych; Małgorzata Chalimoniuk
Journal:  Nutrients       Date:  2018-12-04       Impact factor: 5.717

4.  Effects of low carbohydrate diets high in red meats or poultry, fish and shellfish on plasma lipids and weight loss.

Authors:  Bridget A Cassady; Nicole L Charboneau; Emily E Brys; Kristin A Crouse; Donald C Beitz; Ted Wilson
Journal:  Nutr Metab (Lond)       Date:  2007-10-31       Impact factor: 4.169

5.  Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal.

Authors:  Anthony Accurso; Richard K Bernstein; Annika Dahlqvist; Boris Draznin; Richard D Feinman; Eugene J Fine; Amy Gleed; David B Jacobs; Gabriel Larson; Robert H Lustig; Anssi H Manninen; Samy I McFarlane; Katharine Morrison; Jørgen Vesti Nielsen; Uffe Ravnskov; Karl S Roth; Ricardo Silvestre; James R Sowers; Ralf Sundberg; Jeff S Volek; Eric C Westman; Richard J Wood; Jay Wortman; Mary C Vernon
Journal:  Nutr Metab (Lond)       Date:  2008-04-08       Impact factor: 4.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.